Option Systems Antibacterial Foaming Hand Wash, 0.3% P.C.M.X., 8 fl oz and 18 fl oz. bottles and ...

FDA Drug Recall #D-0002-2018 — Class II — August 23, 2017

Recall Summary

Recall Number D-0002-2018
Classification Class II — Moderate risk
Date Initiated August 23, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Inopak Ltd
Location Ringwood, NJ
Product Type Drugs
Quantity N/A

Product Description

Option Systems Antibacterial Foaming Hand Wash, 0.3% P.C.M.X., 8 fl oz and 18 fl oz. bottles and 500, mL 800 mL, and 1000 mL pouches, ALSO labeled as STYLE Antibacterial Hand Soap, Inopak Ltd Ringwood, NJ --- NDC 5031-431-02

Reason for Recall

GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump

Distribution Pattern

nationwide

Lot / Code Information

Batch Numbers  6718, 6730, 6744, 6754, 6760, 6773, 6784, 6793, 6804, 6812, 6819, 6838, 6846, 6862, 6877, 6890, 6902, 6910, 6919, 6838, 6846, 6862, 6877, 6890, 6902, 6910, 6919, 6938, 6944, Style Batch Numbers  6725, 6732, 6735, 6742, 6756, 6762, 6766, 6770, 6777, 6792, 6798, 6807, 6813, 6816, 6829, 6839, 6868, 6872, 6875, 6891, 6904, 6906, 6914, 6916, 6923, 6932, 6939, 6820

Other Recalls from Inopak Ltd

Recall # Classification Product Date
D-1317-2019 Class II Sani-Guard-SF Waterless Foam Hand Sanitizer, Et... Apr 22, 2019
D-1315-2019 Class II Antibacterial Hand Soap, Healthcare 2000, label... Apr 22, 2019
D-1312-2019 Class II Instant Waterless Hand Sanitizer, Ethyl Alcohol... Apr 22, 2019
D-1319-2019 Class II Unison Hand Care Products, WHITE PEARLIZED Anti... Apr 22, 2019
D-1310-2019 Class II ANTIBACTERIAL Foaming Hand Wash With Moisturize... Apr 22, 2019

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.